Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s Rare Pediatric Voucher Program Faces Tight Deadline For Reauthorization
Sep 04 2024
•
By
Sue Sutter
The sun will start setting on the FDA's rare pediatric disease PRV program on 30 September. • Source: Shutterstock
More from Rare Diseases
More from Pink Sheet